share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  10/21 17:21

Moomoo AI 已提取核心信息

180 Life Sciences Corp. has successfully completed a warrant inducement agreement with a holder of its existing warrants, resulting in the full exercise of warrants for cash and the issuance of new unregistered warrants. The agreement, initially reported on October 16, 2024, led to the holder exercising existing warrants to purchase 950,069 shares of common stock at $3.48 per share on October 16 and 17, 2024. This transaction provided the company with $3,306,240 before expenses. In return, the company issued new warrants to the holder to purchase double the number of shares acquired through the existing warrants at an exercise price of $1.50 per share, exercisable immediately and valid for five years. The issuance of these new warrants is exempt from registration under the Securities Act. The company corrected previous errors in reporting, adjusting the number of shares and the total funds raised from the exercise of the existing warrants. The corrected figures are 950,069 shares and $3,306,240, respectively.
180 Life Sciences Corp. has successfully completed a warrant inducement agreement with a holder of its existing warrants, resulting in the full exercise of warrants for cash and the issuance of new unregistered warrants. The agreement, initially reported on October 16, 2024, led to the holder exercising existing warrants to purchase 950,069 shares of common stock at $3.48 per share on October 16 and 17, 2024. This transaction provided the company with $3,306,240 before expenses. In return, the company issued new warrants to the holder to purchase double the number of shares acquired through the existing warrants at an exercise price of $1.50 per share, exercisable immediately and valid for five years. The issuance of these new warrants is exempt from registration under the Securities Act. The company corrected previous errors in reporting, adjusting the number of shares and the total funds raised from the exercise of the existing warrants. The corrected figures are 950,069 shares and $3,306,240, respectively.
180 Life Sciences Corp.已与持有其现有warrants的持有人成功完成了一项warrant诱因协议，导致warrants全部以现金行使并发行了新的未经注册的warrants。该协议最初于2024年10月16日报告，导致持有人在2024年10月16日和17日行使现有warrants以$3.48每股的价格购买了950,069股普通股。该交易为公司提供了$3,306,240，不包括费用。作为回报，公司向持有人发行了新的warrants，以每股$1.50的价格购买现有warrants获得的股份的两倍数量，立即行使并在五年内有效。这些新warrants的发行符合《证券法》的注册豁免。公司纠正了以前的报告错误，调整了通过行使现有warrants筹集的股份数和总支出金额。相应的更正数据为950,069股和$3,306,240。
180 Life Sciences Corp.已与持有其现有warrants的持有人成功完成了一项warrant诱因协议，导致warrants全部以现金行使并发行了新的未经注册的warrants。该协议最初于2024年10月16日报告，导致持有人在2024年10月16日和17日行使现有warrants以$3.48每股的价格购买了950,069股普通股。该交易为公司提供了$3,306,240，不包括费用。作为回报，公司向持有人发行了新的warrants，以每股$1.50的价格购买现有warrants获得的股份的两倍数量，立即行使并在五年内有效。这些新warrants的发行符合《证券法》的注册豁免。公司纠正了以前的报告错误，调整了通过行使现有warrants筹集的股份数和总支出金额。相应的更正数据为950,069股和$3,306,240。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间